Search our Innovation Portfolio

The primary aim of our project is to empower asthma patients to make environmentally responsible choices about their inhalers, thereby reducing the carbon footprint associated with asthma treatment.

The Digital Health Passport for Epilepsy is a comprehensive digital service being developed by Tiny Medical Apps and Young Epilepsy. It empowers young people to better manage their epilepsy through evidence-based features including medication reordering, seizure tracking, and trigger avoidance tools. Voice control and accessible design ensure equity of access for users with learning disabilities. The platform will integrate with NHS systems to enhance care coordination. Already successful across 10 NHS regions for asthma management, this solution is designed to scale to support the 100,000 young people managing epilepsy in their lives in the UK, with a particular focus on addressing health inequalities in underserved communities.

MARPLE (MagMove Assisted RNA Purification and Lateral flow Evaluation) is an innovative point-of-care diagnostic platform designed to rapidly and accurately differentiate between bacterial and viral infections. Using patent-protected mRNA biomarkers, MARPLE provides results in under 10 minutes from a small blood sample, enabling timely and precise clinical decision-making. The DETECTIVE project focuses on optimising MARPLE’s diagnostic accuracy, validating its performance with clinical samples, and ensuring it is affordable, user-friendly, and scalable for use in NHS A&E departments. By reducing unnecessary antibiotic prescriptions, MARPLE addresses the global challenge of antimicrobial resistance while improving patient care.